China Medical System : ANNOUNCEMENT ON VOTING RESULTS OF ANNUAL GENERAL MEETING ...

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

CHINA MEDICAL SYSTEM HOLDINGS LIMITED

康哲藥業控股有限公司*

(Incorporated in the Cayman Islands with limited liability)

(Stock Code: 867)

ANNOUNCEMENT ON VOTING RESULTS OF ANNUAL GENERAL

MEETING HELD ON 25 APRIL 2019

At the annual general meeting of China Medical System Holdings Limited (the "Company") held on 25 April 2019 (the "AGM"), all the proposed resolutions as set out in the notice of AGM dated 22 March 2019 were taken by poll.

As at the date of the AGM, the total number of issued shares in the Company was 2,480,408,512. In relation to all resolutions proposed at the AGM, the total number of shares entitling the holders to attend and vote for or against the resolutions at the AGM was 2,480,408,512. There is no restriction on any shareholder casting votes on any of the resolution at the AGM.

The Company's branch share registrar, Computershare Hong Kong Investor Services Limited, was appointed as the scrutineer for the purpose of vote-taking at the AGM. Set out below are the poll results of the respective resolutions put to the vote at the AGM:

	Ordinary Resolutions		Number of Votes
			For	Against
	To review, consider and adopt the audited
	consolidated financial statements of the		1,966,028,741	3,103,500
	Group, the reports of the directors of the
			(99.842393%)	(0.157607%)
1	Company and the auditors of the Company
	for the year ended 31 December 2018
	To approve the recommended final dividend		1,968,738,740	887,500
2	of RMB0.1434 (equivalent to HK$0.168) per
			(99.954941%)	(0.045059%)
	share for the year ended 31December 2018
3	(a) To re-elect Ms. Chen Yanling as		1,921,279,475	48,346,765
	executive Director		(97.545384%)	(2.454616%)
*For identification purpose only		1

	(b) To re-elect Mr. Cheung Kam Shing,	1,420,844,148	548,782,092
	Terry as independent non-executive
		(72.137755%)	(27.862245%)
	Director
	(c) To re-elect Mr. Leung Chong Shun as	1,578,787,579	386,892,661
	independent non-executive Director	(80.317620%)	(19.682380%)
	(d) To authorise the board of Directors to fix	1,964,014,470	5,526,770
	the Directors' remuneration	(99.719388%)	(0.280612%)
	To re-appoint Deloitte Touche Tohmatsu as	1,772,896,026	183,324,357
4	auditors of the Company and to authorise the
		(90.628645%)	(9.371355%)
	board of Directors to fix their remuneration
	To grant a general mandate to the Directors	1,353,931,451	615,694,789
5	of the Company to allot, issue and otherwise
		(68.740527%)	(31.259473%)
	deal with unissued shares of the Company
	To grant a general mandate to the Directors	1,968,650,740	890,500
6	of the Company to repurchase shares of the
		(99.954786%)	(0.045214%)
	Company
	To add the nominal amount of the shares
7	repurchased by the Company to the general	1,402,341,653	567,284,587
	mandate granted to the Directors of the	(71.198364%)	(28.801636%)
	Company under resolution No.5 above

As more than 50% of the votes were cast in favour of all the above resolutions, the resolutions were duly passed.

Shareholders may refer to the circular dated 22 March 2019 for details of the above resolutions proposed at the AGM. The circular may be viewed and downloaded from the Company's website at www.cms.net.cnor the designated website of Hong Kong Exchanges and Clearing Limited at www.hkexnews.hk.

On behalf of the Board

China Medical System Holdings Limited

Lam Kong

Chairman

Hong Kong, 25 April 2019

As at the date of the announcement, the directors of the Company comprise (i) Mr. Lam Kong, Mr. Chen Hongbing and Ms. Chen Yanling as executive directors; and (ii) Mr. Cheung Kam Shing, Terry, Mr. Wu Chi Keung and Mr. Leung Chong Shun as independent non-executive directors.

2